Sci-Tech North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.

Press releases published on October 14, 2026

2 hours ago

Printful Publishes 2026 Guide to Etsy Print-on-Demand Profitability

Indeterminate EIN Presswire

9 minutes ago

BVR ONE PARTNERS WITH FOUNDER OF MARKETING FOR SHIBA INU, RUSS DAVIS TO BUILD THE NEXT GENERATION OF LOYALTY PROGRAM

Indeterminate GlobeNewswire

19 minutes ago

Purespring Therapeutics to present new data on pipeline progress in Alport Syndrome at the American Society of Nephrology (ASN) Kidney Week 2026

Indeterminate GlobeNewswire

20 minutes ago

IP Services Announces Expanded Focus on Executive Cybersecurity and AI Governance Under Scott Alldridge

Indeterminate GlobeNewswire

34 minutes ago

Calian awarded CAD$47 million contract for NATO Joint Warfare Centre scenario development program

Indeterminate GlobeNewswire

38 minutes ago

Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome

Indeterminate GlobeNewswire

38 minutes ago

BreathiZen Introduces BreathiZen Spray With Mullein Leaf Extract, Ginger Root Extract, Bromelain, and Organic Lemon Extract 60 ml

Indeterminate GlobeNewswire

39 minutes ago

Eden Project Grows Live Learning with LiveU Technology

Indeterminate GlobeNewswire

39 minutes ago

Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study

Indeterminate GlobeNewswire

39 minutes ago

Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

39 minutes ago

Why Today’s Affordability Crisis Has Become a Workplace Challenge - New Kashable White Paper

Indeterminate GlobeNewswire

39 minutes ago

Orvida Pharma Announces FDA Acceptance of KM-023 (ontivatrep) into Rare Disease Evidence Principles Process for Olmsted Syndrome

Indeterminate GlobeNewswire

39 minutes ago

Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45

Indeterminate GlobeNewswire

39 minutes ago

Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington's Disease Franchise

Indeterminate GlobeNewswire

39 minutes ago

Elion Therapeutics Expands Pipeline with Exclusive Global License to Inhaled Antifungal for Immunocompromised Patients

Indeterminate GlobeNewswire

39 minutes ago

OutSolve Releases New Report Examining the Surge in I-9 Enforcement and Its Impact on Employers

Indeterminate GlobeNewswire

39 minutes ago

Marovi Opens Its Evaluation Intelligence Engine to Executives Exploring Their Next Move

Indeterminate GlobeNewswire

39 minutes ago

Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis

Indeterminate GlobeNewswire

39 minutes ago

Climb adds Netwrix to its Security Portfolio, Bringing Data and Identity Security to VARs and MSPs

Indeterminate GlobeNewswire

39 minutes ago

Seyond to Showcase Live LiDAR Operational Twin Demo at Dell Technologies and NVIDIA Booth at Smart City Expo World Congress 2026

Indeterminate GlobeNewswire